awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q38218013-1B46FDF1-4594-4C5A-AF5A-54B516E49843
Q38218013-1B46FDF1-4594-4C5A-AF5A-54B516E49843
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38218013-1B46FDF1-4594-4C5A-AF5A-54B516E49843
Monoclonal antibodies: pharmacokinetics as a basis for new dosage regimens?
P2860
Q38218013-1B46FDF1-4594-4C5A-AF5A-54B516E49843
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38218013-1B46FDF1-4594-4C5A-AF5A-54B516E49843
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
f07371ca2321cae79623368bdc3a1ba74f0fd3b7
P2860
Subcutaneous versus intravenous administration of (neo)adjuvant trastuzumab in patients with HER2-positive, clinical stage I–III breast cancer (HannaH study): a phase 3, open-label, multicentre, randomised trial